Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: A meta-analysis [4]

Clinical Oncology

Volumn 16, Issue 1, 2004, Pages 82-

  Green, J A ^a  

^a CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ERYTHROPOIETIN;

ANEMIA; BLOOD TRANSFUSION; CALCULATION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMORBIDITY; DATA ANALYSIS; FOLLOW UP; HEALTH CARE POLICY; HIGH RISK PATIENT; HUMAN; HYPOXIA; LETTER; MEDICAL LITERATURE; META ANALYSIS; MINIMAL RESIDUAL DISEASE; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; SIDE EFFECT; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER;

EID: 1042303685     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2003.08.004     Document Type: Letter

References (8)

1. Lukka H, Hirte H, Fyles A, et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis. Clin Oncol 2002;14:203-212.
2. Symonds P. Chemoradiation: the new gold standard for non-surgical treatment of cervical cancer. Clin Oncol 2002;14:201-202.
3. Green JA, Kirwan JM, Tierney JE, el al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001; 358:781-786.
4. Peters WA, Lin PY, Barrett RJ. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-1613.
5. Thomas G. Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care. Semin Radiat Oncol 2000;10:44-50.
6. Rose PG. Chemoradiotherapy for cervical cancer. Eur J Cancer 2002;38:270-278.
7. Stewart L, Tierney J. Neoadjuvant chemotherapy followed by surgery for locally advanced cervical cancer: a meta-analysis using individual patient data from randomised controlled trials (RCTs). Proc ASCO 2002;21:207a.
8. Blohmer JU, Wurschmidt F, Petry G, et al. Sixth interim analysis of a prospective, randomised open and controlled AGO- and NOGGO-Intergroup study: sequential adjuvant chemoradiotherapy with vs without epoetin alfa for patients with high risk cervical cancer. Proc ASCO 2003;22:447a.